Meta’s Targeted Healthcare Advertising Changes: What Life Science Marketers Need to Know

What’s Changing in Meta’s Healthcare Advertising Policies?

Starting January 2025, these updates will significantly impact healthcare marketers:

• Data Sharing Restrictions: Certain websites and apps will face limitations on data sharing.
• Loss of Conversion Campaigns: Condition-specific sites, such as treatmigraines.com, will no longer be able to run website conversion campaigns.

Meta will categorize all business data sources (e.g., pixels, conversion APIs, domains) into healthcare-related classifications:

• Fully Restricted Properties: Websites focused on specific health conditions may lose access to conversion campaigns entirely. If your organisation's website or domain falls into this category, it will mean you won’t be able to run Meta ad campaigns with goals like conversions or events involving leads, registrations, or purchases. Additionally, you’ll lose the ability to create retargeting or lookalike audiences based on restricted events, which is unfortunate as these strategies often perform well over time. On the bright side, higher-funnel objectives like awareness, engagement, and traffic will remain unaffected, allowing you to focus on building visibility and audience interaction.
• Mid-Restricted Properties: Broader domains, like hospital websites, will face limited lower-funnel optimization capabilities such as "purchase" or "add to cart", but may still run some campaign types.

Meta themselves say: “When a data source is categorized under a category with restrictions, we may limit or fully restrict the ability to share event data with us via the Meta Business Tools. If we decide to limit or fully restrict a data source from sharing event data with us, we will inform you via email and notifications in Meta Events Manager.”

These changes show Meta’s commitment to stronger privacy controls, and it means you’ll need to rethink and adapt your strategies to stay compliant.

How it worked before

Currently, you might use the Meta pixel or conversions API to track user actions after clicking on ads, such as visits to sites, product views, completed transactions, signing petitions, making donations, or taking other actions. This data helps Meta’s algorithm optimise ad performance by identifying the best audiences to target.

For instance, if a user clicked on an ad for a prescription drug, visited the brand’s website, and completed a purchase, Meta could track this behaviour and show similar ads to other users with comparable online habits.

How Meta's Changes Could Impact Your Marketing Results  

As a life science marketer, these changes could have a significant impact on your campaigns:  

• Restricted Ad Targeting: You can no longer use data tied to health and medical conditions to target your audience with the same precision. For instance, targeting users who have purchased diabetes medication or engaged with chronic pain solution ads is now off-limits.  
• Impact on Conversion Rates: Without access to specific health-related data, reaching high-intent audiences may become more challenging, potentially affecting your conversion rates.  

These shifts challenge you to find innovative, responsible ways to connect with your target audience while prioritizing user privacy.  Adaptability will be key to navigating these changes effectively.

Adapting Your Strategy to Meta’s New Policy  

Meta’s updated restrictions bring new challenges, but they also offer an opportunity to rethink and refine your healthcare advertising approach. Here are actionable steps to help you navigate and adapt to these changes effectively:  

1. Audit Your Data Sources  

Start by reviewing and categorizing your data sources based on their restriction levels—fully restricted, mid-restricted, or unrestricted. This will provide clarity on which data can continue to be utilized and where adjustments are needed.  

2. Focus on Registered Custom Events  

To comply with Meta’s updated policies, ensure all event tracking data adheres to their privacy requirements. Registered custom events allow you to monitor specific actions on your site while maintaining compliance. For example:  

• Track general user behaviors such as newsletter sign-ups or white-paper downloads without involving sensitive health or purchase-related information.  
• Align your custom event definitions with Meta’s guidelines to avoid any compliance issues.  

3. Leverage Aggregated and Anonymous Data  

Privacy concerns and restrictions mean marketers must prioritize aggregated data over personally identifiable information. By focusing on broader audience trends and behaviors, you can gain valuable insights while staying privacy-compliant. Ensure your data collection is consent-driven and take steps to maximize the value of first-party data.  

4. Invest in First-Party Data Strategies  

With the limitations on third-party data, organisations with strong first-party data collection programmes are well-positioned to weather these changes. Email lists will become increasingly valuable as privacy policies become more restrictive, making lead generation an essential component of digital programmes.

By capturing insights directly from your audience, you’ll reduce dependency on external platforms and strengthen your targeting efforts.  

5. Use Tools Designed for Compliance  

Simplify compliance and optimize your healthcare campaigns with platforms like RoseRx. RoseRx offers built-in protections to ensure your advertising aligns with evolving privacy standards while delivering measurable results. Their tailored tools for life sciences marketers include:  

• Fully compliant custom event tracking  
• Advanced AI to optimize campaigns using aggregated data  
• Seamless adaptation to ongoing policy changes  

6. Monitor Events Manager for restrictions  

Between January 6 and January 13, 2025, check Events Manager for any notifications about potential restrictions. If flagged, request a 30-day extension within the 7-day window to adjust your campaigns and stay compliant.

7. Review your media buying strategy and platform diversification  

• We recommend shifting focus to higher-funnel objectives, such as Awareness (reach, impressions) or Traffic (link clicks).  
• Optimize for earlier journey events, such as “add_payment_info” or landing page views (e.g., thank-you pages) as proxies for conversions.  
• To maintain campaign reach and performance, we suggest reducing reliance on Meta by testing alternative platforms like Google Ads, YouTube, TikTok, or programmatic advertising.

Why RoseRx is the Partner You Need  

Compliance doesn’t have to be complicated or mean sacrificing results—it’s an opportunity to create stronger, more meaningful engagement for your organisation. At RoseRx, we offer ready-to-use solutions that help life science marketers like you drive results while staying aligned with the latest data privacy standards. Let’s talk about how we can support your healthcare platform infrastructure and take your success to the next level.

Article Summary

Meta's New Policies (Jan 2025): Stricter data sharing and ad targeting rules will limit conversion campaigns for health-related domains.

‍